INTERVIEW: Re-energised Cytox readies Alzheimer's test for pharma partnership in H2 2013
This article was originally published in Scrip
In spite of being close to shuttering its doors some 18 months ago, Cytox has now risen from the ashes to take on the Alzheimer's diagnostic market, with its coffers filled and a new CEO at the helm.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.